The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator
Philip E. Brandish, Kenneth Anderson, Gretchen A. Baltus, Chang Bai, Christopher J. Bungard, Patricia Bunting, Alan Byford, Chi Sung Chiu, Milenko Cicmil, Halea Corcoran, Danielle Euler, John E. Fisher, Carlo Gambone, Martha Hasbun-Manning, Nelly Kuklin, Elizabeth Landis, Traci Q. Lifsted, Sheila McElwee-Witmer, Ian S. McIntosh, Robert S. MeissnerJohn Miao, Helen J. Mitchell, Amy Musselman, Azriel Schmidt, John Shin, Peter Szczerba, Charles D. Thompson, Catherine Tribouley, Robert L. Vogel, Sudha Warrier, James C. Hershey
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator'. Together they form a unique fingerprint.